The CXCR6/CXCL16 axis links inflamm-aging to disease severity in COVID-19 patients
D. J. Payne, S. Dalal, R. Leach, R. Parker, S. Griffin, C. S. McKimmie, G. P. Cook, S. J. Richards, P. Hillmen, T. Munir, L. Arnold, K. Riley, C. McKinley, S. Place, R. L. Baretto, D. J. Newton
This study examines the role of the CXCR6/CXCL16 axis in severe COVID-19, finding elevated CD8+CXCR6+ T cells with age and increased CXCL16 levels in severe cases.
bioRxiv · Jan 25, 2021 · PreprintImmunology